Immunogenicity Studies of Cosmetically Administered Nonanimal-Stabilized Hyaluronic Acid Particles

Abstract

NASHA administration does not elicit clinical/laboratory evidence for cellular or humoral immune responses in 98% of individuals, supporting the conclusion that Restylane and/or Perlane are not commonly immunogenic or allergenic.